AstraZeneca
highlights accelerating our ambition in immune mediated diseases innovative immunology portfolio investing in cell therapies with curative potential | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
23 of 45
Related slides by other companies
Nano Dimension
Shareholder Engagement
August 2023
our disciplined capital allocation strategy positions dimension for the next phase | Nano Dimension
argenx SE
Investor Presentation
November 2023
myositis trial | argenx SE
Other recent decks by AstraZeneca
See all presentations (27 decks)
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io